Pre-pregnancy risk assessment and counselling of the cardiac patient

Netherlands Heart Journal

Volumn 19, Issue 11, 2011, Pages 477-481

  Pieper, P G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Counselling; Heart disease; Pregnancy; Risk

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AORTA DISEASE; ARTICLE; CARDIAC PATIENT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; CONTRACEPTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; HUMAN; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; MATERNAL WELFARE; PATIENT COUNSELING; PATIENT INFORMATION; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PROGENY; RISK ASSESSMENT; TREATMENT DURATION; VALVULAR HEART DISEASE;

EID: 83155165524     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0188-z     Document Type: Article

References (17)

1. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.
2. Curtis SL, Marsden-Williams J, Sullivan C, et al. Current trends in the management of heart disease in pregnancy. Int J Card. 2009;133:62-9.
3. Schutte JM, Steggers EAP, Schuitemaker NEW, et al. The Netherlands Maternal Mortality Committee. Rise in maternal mortality in the Netherlands. BJOG. 2010;117:399-406.
4. Khairy P, Ouyang D, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circ. 2006;113:517-24.
5. Kovavisarach E, Nualplot P. Outcome of pregnancy among parturients complicated with heart disease in Rajavithi hospital. J Med As Thai. 2007;90(11):2253-9.
6. Song YB, Park SW, Kim JH, et al. Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci. 2008;23:808-13.
7. Drenthen W, Boersma E, Balci A, On behalf of the ZAHARA investigators, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124-32.
8. Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Card. 2010;56:1247-53.
9. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease. A literature review. J Am Coll Card. 2007;49(24):2302-11.
10. Balci A, Sollie KM, Mulder BJ, et al. Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Heart J. 2011 Feb;161(2):269-75.
11. Jastrow N, Meyer P, Khairy P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Card 2010. doi:10.1016/j.ijcard.2010.05.045.
12. Balci A, Sollie KW, Mulder BJ, et al. Prospective assessment of pregnancy risk estimation models in women with congenital heart disease. Eur Heart J. 2010;31(SupplI):615-6.
13. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J 2011. doi:10.1093/eurheartj/ehr218.
14. Yap SC, Drenthen W, Pieper PG, et al. On behalf of the ZAHARA INvestigators. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008;126:240-246.
15. Yap SC, Drenthen W, Pieper PG, et al. Outcome of Pregnancy In Women After Pulmonary Autograft Replacement For Congenital Aortic Valve Disease. J Heart Valve Dis. 2007 Jul;16(4):398-403.
16. Krul SP, van der Smagt JJ, van den Berg MP, et al. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail. 2011; Apr 11 (Epub ahead of print).
17. Thorne S, McGregor A, Nelson-Piercy C. Risk of contraception and pregnancy in heart disease. Heart. 2006;92:1520-5.